Deciphera Pharmaceuticals Receives $75,604,034 New Round

  • Feed Type
  • Date
    7/15/2016
  • Company Name
    Deciphera Pharmaceuticals
  • Mailing Address
    1601 Trapelo Road Waltham, MA 02451 USA
  • Company Description
    Deciphera Pharmaceuticals, LLC was established in 2003 as a drug discovery and development company with the mission to design, optimize and introduce best-in-class small molecule switch inhibitors of protein kinases for human clinical trials and the global pharmaceutical marketplace through the use of its proprietary drug discovery technology platform.
  • Website
    http://www.deciphera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $75,604,034
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 5 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy